Similar articles

• Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome.

  Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, Hanada R, Kinoshita A, Sakurai M, Kobayashi N, et al. Kawaguchi H, et al. J Clin Invest. 1993 Sep;92(3):1444-50. doi: 10.1172/JCI116721. J Clin Invest. 1993. PMID: 8397226 Free PMC article.
• Fatal Epstein-Barr virus-associated hemophagocytic syndrome.

  Kikuta H, Sakiyama Y, Matsumoto S, Oh-Ishi T, Nakano T, Nagashima T, Oka T, Hironaka T, Hirai K. Kikuta H, et al. Blood. 1993 Dec 1;82(11):3259-64. Blood. 1993. PMID: 8241498
• Epstein-Barr virus-associated haemophagocytic syndrome in a patient with juvenile chronic arthritis.

  Davies SV, Dean JD, Wardrop CA, Jones JH. Davies SV, et al. Br J Rheumatol. 1994 May;33(5):495-7. doi: 10.1093/rheumatology/33.5.495. Br J Rheumatol. 1994. PMID: 8173858
• Molecular basis for Epstein-Barr virus induced pathogenesis and disease.

  Sample C, Kieff E. Sample C, et al. Springer Semin Immunopathol. 1991;13(2):133-46. doi: 10.1007/BF00201464. Springer Semin Immunopathol. 1991. PMID: 1664982 Review. No abstract available.
• [Evidence of cause--effect relationship between Epstein-Barr virus and atherosclerosis].

  Kupchinskiĭ RA. Kupchinskiĭ RA. Kardiologiia. 1993;33(4):66-70. Kardiologiia. 1993. PMID: 7933798 Review. Russian. No abstract available.